Samples for Eurofins Clinical Genetics Ireland are received by the Pre‑Analytics department in Blackthorn Road, Sandyford (Eurofins Biomnis Ireland) and then forwarded to our Eurofins Clinical Genetics laboratory in the UK.
Eurofins Clinical Genetics Ireland is a state-of-the-art, next-generation sequencing laboratory in Dublin. This laboratory offers advanced clinical genetics services, while maintaining a strong focus on advancing clinical research in our dedicated research and development laboratory at our Dublin site. This combination of entrepreneurship and intellectual academia via our University Partner, allows Eurofins Clinical Genetics Ireland to bring predictive medicine to the Irish population.
TTMI, St. James' Hospital,Dublin, Campus, Dublin 8, Ireland
Laboratory+353 (0) 1 295 8545
Samples for Eurofins Clinical Genetics Ireland are received by the Pre‑Analytics department in Blackthorn Road, Sandyford (Eurofins Biomnis Ireland) and then forwarded to our Eurofins Clinical Genetics laboratory in the UK.
The vast majority of erroneous results are caused by errors made during sample collection and transport, rather than analytical errors within the laboratory. For this reason, it is essential that correct procedures are followed for patient preparation, sample collection, sample preparation, and sample transport. The following procedures should always be followed.
We require at least two identifiers for every patient, both on the request form and on each sample tube. A minimum of the following are required: surname and given name, date of birth. If these are not present, the samples cannot be processed.
Samples with inadequate volume or that are sent in non-validated or expired tubes will be rejected.
Eurofins Biomnis provide a Buccal Swab kit. To order this kit, please email orders@ctie.eurofinseu.com.
Samples with inadequate volume or that are sent in non-validated or expired tubes will be rejected.
Streck tubes and Buccal Swabs are to be stored at room temperature or refrigerated at 2-8°C until shipment. Samples should be shipped between 4°C and 30°C.
Do not keep Streck tubes in the freezer. Samples must be sent to the laboratory using the transport container provided, assembled to UN 3373 standards. Following blood draw, samples should be shipped as soon as possible.
Please follow the instructions below for packaging and shipping the samples:
Driver pickup: Email Eurofins Lablink on logistics@ctie.eurofinseu.com to schedule a collection by a Eurofins driver.
Samples must arrive at the laboratory within five days from blood draw for a validated result.
Public Opening Hours:
Monday to Sunday: 8.30am - 5.30pm
Unit 3, Sandyford Business Centre, Sandyford Business Park, Blackthorn Road, Dublin 18,D18 E528,Ireland
Tel: 1800 252 967
Email: lablinklogistics@ctie.eurofinseu.com
Public Opening Hours:
Monday to Friday: 8.30am - 5.30pm
Tel: 1800 252 966
Email: clientservices@ctie.eurofinseu.com
We currently offer Prenatalsafe® 3 & 5.
By analysing the cell-free fetal DNA (cffDNA) circulating in the mother’s blood, this new non-invasive prenatal test can screen for chromosomal aneuploidies and or serious genetic disease of the developing fetus.
Any expectant mother, single or twin pregnancies, conceived either through natural conception or medically assisted reproductive technologies, whether autologous or heterologous.
PNS3 is available for singleton and twin pregnancies.
PNS5 only available for singleton pregancies.
Fetal sex determination in twin pregnancies only detects presence or absence of Y chromosome.
Prenatalsafe® is a non-invasive prenatal test (NIPT) designed to detect the presence of chromosomal errors and genetic diseases in the developing fetus during early pregnancy (from 10 weeks). The tests are non-invasive and are performed on a simple blood sample from the mother, thus minimising risk to the fetus. The tests analyse fetal genetic material that occurs naturally in the mother’s blood during pregnancy.
Unfortunately, the prevention of chromosomal abnormalities during pregnancy is impossible. NIPT for the detection of chromosomal and genetic errors make it possible for prospective parents to receive information about the health of their baby as soon as possible. This enables them along with their clinician to make informed decisions about crucial medical management, their pregnancy, and the future of their family.
Speak to your doctor, midwife, or consultant if you are interested in any of the NIPT options provided by Eurofins Clinical Genetics Ireland. Your healthcare provider will be sent your results and advise you on the next steps.
During pregnancy, some fragments of the baby's DNA circulate in the mother's blood. Fetal DNA is detectable starting from the 5th week of gestation. Its concentration increases through gestation and disappears immediately after delivery.
The quantity of fetal DNA circulating from the 10th week of gestation is sufficient to guarantee the high specificity and sensitivity of the test. The test is performed on a blood sample from the mother with a gestational age of at least 10 weeks.
Through a specialised laboratory process, the cell-free circulating fetal DNA is isolated from the plasma of the maternal blood sample.
Subsequently, the entire fetal genome (cfDNA) is sequenced, using the innovative massive parallel sequencing (MPS) / Next Generation Sequencing (NGS) platforms from ILLUMINA.
The chromosomal DNA sequences are finally analysed by a bioinformatics tool to determine the presence of any fetal chromosomal aneuploidies or structural abnormalities.
Conceived through natural conception or assisted reproductive techniques.
Conceived through natural conception or assisted reproductive techniques.
Pregnancies ended in miscarriage or voluntary termination.
If you are looking to open an account with Eurofins Clinical Genetics, please make sure to download both Part 1 and Part 2 of the forms below. Both forms need to be fully filled out and emailed back to marketing@ctie.eurofinseu.com to begin the onboarding process.
Our company's policy is to continuously assess and enhance the quality of service provided to our customers. Our Quality Management Department continuously monitor our policies and procedures, which is crucial in making sure every department operates to the necessary standard. As of June 2025 Eurofins Clinical Genetics was awarded ISO 15189:2022 accreditation, a testament to the hard work and determination of the entire team. To view the certificate or scope of accreditation please follow the link below:
Communication to patients\doctors:
In keeping with the Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023, it is the policy of Eurofins Biomnis that requesting clinicians and patients are communicated with in an open, honest, transparent and empathetic manner following a patient safety or notifiable incident; that they are provided with a sincere and meaningful apology, especially when they are harmed as a result of such incidents; and that this communication process is initiated in a timely manner. Open disclosure is a feature of high-quality health care, and is an important contributor to patient safety.
This Privacy Notice is intended to assist you in making informed decisions when using the website and our services and/or to understand how your personal information may be processed by us as a result of providing the services or when you apply to work at Eurofins Biomnis / Eurofins Pathology / Eurofins Lablink, Eurofins Clinical Genetics, (“Eurofins”). Please take a moment to read and understand it. This privacy notice should be read in conjunction with our Cookies Notice.
Cookie Notice.
Eurofins Data Protection Officer
Email: DPO@CTIE.eurofinseu.com
Please note: Where the laboratory is required by law or authorised by contractual arrangements to release confidential information, the original requestor will be notified of the information to be released, unless prohibited by law. This applies in particular to the notification of infectious diseases. We are obliged by law to notify cases of notifiable diseases to Public Health. Such notification includes the diagnosis, patient name and date of birth, and patient address. https://www.hpsc.ie/notifiablediseases/notifyinginfectiousdiseases/
Eurofins Biomnis Ireland Limited, Eurofins Pathology, Eurofins Lablink, Eurofins Clinical Genetics
("Eurofins");
Address: Three Rock Road, Sandyford Business Estate, Dublin 18, D18 A4C0, Ireland
NOTE:
Eurofins is both a Data Controller and a Data Processor, with different obligations.
As a Data Controller, we process data, for example for our employees and/or prospective
candidates that may apply to advertised positions with Eurofins and/or individuals that
contact us regarding our services.
As a Data Processor, we process data on behalf of our Clients (‘Data Controllers’),
including healthcare professionals (Doctors/GPs/Consultants/Hospitals) involving patient
data. Should a ‘Data Subject Access Request (DSAR)’ be made to Eurofins as a Data
Processor by a Patient and/or by someone representing a Patient, then the Client must be
notified of such request in compliance with data protection legislation and regulation, as the
Client is responsible to engage directly with the patient and address the Patient’ DSAR
request.
The Client decides as to whether such health data / information is to be disclosed to a Patient. Eurofins does not disclose processed health data / health information directly to a Patient.
We collect the personal information through your completion of the ‘Web-Form’ Contact Us - and/or when you submit information to us by other means (e.g. electronic email, facsimile, post).
When you use the Web-Form, such personal information usually consists of:
The purpose of the web-form is for queries you have. We will then reply and contact you by email or phone in response to provide more information regarding your specific enquiry. You should only give us the personal information requested in the web-form and if you do not agree to provide us with this information, you must not fill in the web form.
Information that is provided by you through other means will be assessed, processed and responded to.
We will use the information we collect through the web-form for the following purposes:
Depending on your business relationship you have with us and/or your type of query we may process the following types of data:
To undertake these as listed above we may process the following personal information:
If you are a visitor to the website and use the web-form:
If you are a client in receipt of our Services or prospective individual / client:
If you are a potential recruit to join Eurofins:
Where we process personal data you provide, our legal basis in compliance with GDPR, for processing will vary depending on the circumstances. Ordinarily, the relevant legal basis is that the processing is:
Processing is necessary for the purposes of preventive or occupational medicine, for the assessment of the working capacity of the employee, the provision of health (i.e. testing of samples provided to us by healthcare professionals on behalf of their patients) or for the management of our healthcare systems and services on the basis pursuant to contracts with a healthcare professionals (e.g. hospitals / GP Doctors).
In order to process personal data, we lawfully rely on at least one of the following GDPR regulatory requirements:
the data subject has given consent to the processing of his or her personal data for one or more specific purposes;
processing is necessary for the performance of a contract to which the data subject is party or in order to take steps at the request of the data subject prior to entering into a contract;
processing is necessary for compliance with a legal obligation to which the data controller / data processor is subject;
processing is necessary for the purposes of legitimate interests
Transfers are subject to appropriate safeguards in compliance with GDPR Article 46. Approved standard contractual clauses (together with equivalent terms required by other relevant/applicable laws) are to ensure we will comply with our legal and regulatory obligations in relation to personal information, including having a lawful basis for transferring personal information outside of EU and putting appropriate safeguards in place to ensure an adequate level of protection for the personal information.
Your personal data might be transferred outside the EU/EEA only to countries for which:
You have the following rights in relation to the personal data we hold for you:
You also have the right to complain to the relevant national data protection authority in case these rights are not complied with. An overview of the national data protection authorities is available at the following link https://www.edpb.europa.eu/about-edpb/about-edpb/members_en
Your personal data will be stored for a limited period of time, determined with regards to the necessity, and to serve the purposes for which data has been collected and processed. Also, please note that some data retention periods are set by other statute laws (legislation) and/or regulations, depending on the type of data processed (e.g. such as information needed for income tax and audit purposes, or information on aspects of health and safety, and/or information to defend litigation issues etc.).
Any queries you may have, should be sent by email to:
Eurofins Data Protection Officer
Email: DPO@CTIE.eurofinseu.com